Skip to main content
. 2014 Jun 20;7:1135–1141. doi: 10.2147/OTT.S62561

Table 1.

The clinicopathological features of patients at PUMCH

Case Age (years) Primary site Presenting symptom Preoperative diagnosis Metastasis Chemotherapy Surgery Histology Death Outcome OS (months)
1 28 Testis Testis enlargement No Lung, brain FAEV × 3 Orchiectomy CC + IMT Yes Progress >6
2 17 Testis Mass on testis No No EMA/CO × 8; EMA/EP × 2 Orchiectomy CC + MT No Complete remission 138
3 42 Testis Mass on testis No Lung EMA/CO × 4; EMA/EP × 7 Orchiectomy, Metastatic tumor resection CC + embryonal carcinoma No Complete remission 54
4 35 Testis Mass on testis No No No Orchiectomy CC + MT No Complete remission 53
5 33 Mediastinum Hemoptysis No Lung PVB/PEB × 5; EMA/CO × 5: EMA/EP × 5; IEP × 6; MEP × 3; other × 3 Lung lesion resection, mediastinal biopsy CC No Complete remission 115
6 24 Mediastinum Coughing, hemoptysis, mediastinal mass Yes No EMA/CO × 3; PEB × 3 Mediastinal tumor partial resection CC Yes Progress 9
7 31 Mediastinum Dysphagia No Lung EMA/CO × 6; EP × 1; PVE × 3 Mediastinal tumor resection CC + IMT Yes Progress 9
8 16 Pineal body Intracranial hypertension symptoms No Lung EMA/CO × 2; FAEV × 5 Emergency craniotomy, total resection of tumor CC Yes Progress 7
9 6 Pineal body Peripheral precocious puberty Yes No IFO + DDP + VP16 × 3 Craniotomy, total resection of tumor CC No Complete remission 13
10 45 Lung Fainting No Brain EMA/CO × 9 Left occipital craniotomy, lung biopsy CC Yes Relapse 10
11 49 Retroperitoneal Retroperitoneal mass No Lung, bone VAC × 3; PVB × 3; EMA/CO × 5 FAEV × 4; MTX × 4 Total resection of tumor, Metastatic tumor resection CC + IMT Yes Relapse 54
12 52 days Jejunum Hematochezia No Lung EMA × 1; MTX × 3 Partial jejunum resection CC No Complete remission 60
13 55 Stomach Stomach discomfort Yes Liver, retroperitoneal EMA/CO × 4; FAEV × 1 Subtotal gastrectomy CC Yes Progress 6

Abbreviations: CC, choriocarcinoma; EMA/CO, actinomycin D, etoposide, methotrexate, cyclophosphamide, vincristine; EMA/EP, actinomycin D, etoposide, methotrexate, cisplatin (DDP); FAEV, 5-fluorouracil, actinomycin D, etoposide; IEP, carboplatin, etoposide, ifosfamide (IFO); IMT, immature teratoma; MEP, cisplatin, mitomycin, etoposide; MT, mature teratoma; PUMCH, Peking Union Medical College Hospital; PVB/PEB, cisplatin, vincristine, bleomycin/vincristine; VAC, vincristine, actinomycin D, cyclophosphamide; OS, overall survival; PVE, vindesine, cisplatin, etoposide; VP16, etoposide; MTX, methotrexate.